|
Combined chemotherapy
and radiation following rectal cancer surgery, which is now the
standard of care for locally advanced rectal cancer in the United
States, also would benefit elderly patients with stage III rectal
cance, according to New York researchers.
Dr. Alfred
I. Neugut of New York Presbyterian Hospital reported in the Journal
of Clinical Oncology on his review of more than 1,800 patients
over age 65 with stage II or III rectal cancer who underwent surgery
between 1992 and 1996.
He said approximately
one-third of the patients received both chemotherapy and radiation
following their surgeries.
"Combined
chemotherapy and radiation therapy was associated with improved
survival for stage III, but not for stage II rectal cancer,"
Neugut and colleagues reported.
"In the
absence of data from well-designed randomized controlled trials,
our observational data support efforts on the part of clinicians
to make appropriate referrals and provide combined treatment for
elderly patients with stage III rectal cancer," the researchers
concluded.
Other
sources: Journal of Clinical Oncology
|